Saba Capital Management, L.P. Acquires 15,455 Shares of BlackRock Health Sciences Term Trust (NYSE:BMEZ) Stock

BlackRock Health Sciences Term Trust (NYSE:BMEZ) major shareholder Saba Capital Management, L.P. purchased 15,455 shares of the firm’s stock in a transaction on Thursday, September 19th. The shares were acquired at an average cost of 16.14 per share, with a total value of 249,443.70. Following the completion of the acquisition, the insider now directly owns 20,601,568 shares in the company, valued at 332,509,307.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Saba Capital Management, L.P. also recently made the following trade(s):

• On Monday, September 23rd, Saba Capital Management, L.P. bought 2,006 shares of BlackRock Health Sciences Term Trust stock. The shares were acquired at an average cost of 15.98 per share, for a total transaction of 32,055.88.
• On Tuesday, September 17th, Saba Capital Management, L.P. purchased 27,148 shares of BlackRock Health Sciences Term Trust stock. The stock was bought at an average price of 15.93 per share, for a total transaction of 432,467.64.

BlackRock Health Sciences Term Trust Stock Performance

Shares of NYSE:BMEZ opened at 15.72 on Thursday. The firm has a 50 day simple moving average of 15.84 and a 200-day simple moving average of 15.54. BlackRock Health Sciences Term Trust has a twelve month low of 12.93 and a twelve month high of 16.59.

BlackRock Health Sciences Term Trust Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be given a $0.176 dividend. The ex-dividend date is Tuesday, October 15th. This represents a $2.11 dividend on an annualized basis and a yield of 13.43%.

Institutional Trading of BlackRock Health Sciences Term Trust

Hedge funds and other institutional investors have recently made changes to their positions in the company. Pine Valley Investments Ltd Liability Co boosted its holdings in shares of BlackRock Health Sciences Term Trust by 6.7% in the fourth quarter. Pine Valley Investments Ltd Liability Co now owns 13,088 shares of the company’s stock valued at $192,000 after acquiring an additional 822 shares during the period. Dakota Wealth Management boosted its stake in BlackRock Health Sciences Term Trust by 5.3% during the 2nd quarter. Dakota Wealth Management now owns 18,242 shares of the company’s stock worth $280,000 after purchasing an additional 915 shares during the period. Benjamin F. Edwards & Company Inc. grew its position in BlackRock Health Sciences Term Trust by 21.7% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 5,830 shares of the company’s stock worth $96,000 after purchasing an additional 1,038 shares during the last quarter. Oppenheimer & Co. Inc. increased its stake in BlackRock Health Sciences Term Trust by 2.0% in the fourth quarter. Oppenheimer & Co. Inc. now owns 76,699 shares of the company’s stock valued at $1,124,000 after purchasing an additional 1,536 shares during the period. Finally, Kingswood Wealth Advisors LLC raised its holdings in shares of BlackRock Health Sciences Term Trust by 9.2% in the first quarter. Kingswood Wealth Advisors LLC now owns 21,988 shares of the company’s stock valued at $360,000 after buying an additional 1,845 shares during the last quarter.

About BlackRock Health Sciences Term Trust

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.